サノフィ株式会社 News Releases

Sanofi Announces Results of 2026 "Pediatric Atopic Dermatitis Treatment Landscape Survey" Targeting Parents of Children with Moderate to Severe Symptoms

Sanofi K.K. (Headquarters: Shinjuku-ku, Tokyo; President and CEO: Toshihiko Iwaiya) has conducted th… · 2026-06-29

Sanofi Publishes White Paper on 'Atopic Dermatitis Patients and Employment'

Sanofi K.K. has published a white paper titled 'Atopic Dermatitis Patients and Employment,' which in… · 2026-06-18